GARDASIL is the first HPV vaccine approved for the prevention of certain HPV-related cancers and diseases in Chinese males ...

Merck's Gardasil vaccine, previously only available to women, has now been approved for men in China. This approval may help ...

Merck's human papillomavirus vaccine has been approved for men in China, it said on Wednesday, providing the U.S. drugmaker a ...

U.S. drugmaker Merck & Co has received approval in China for its HPV vaccine's use in males, expanding its market reach despite earlier weak sales in the region. This move marks a potential growth ...

The HPV vaccine, Gardasil, has gained approval for additional indications from China's National Medical Products ...

We recently published a list of Jim Cramer Discussed These 29 Stocks Ahead Of Major AI Event. In this article, we are going ...

China’s drug regulator approved Merck & Co.’s blockbuster HPV vaccine for use by men, opening a new untapped market for the ...

With a market cap of $252.6 billion, Rahway, New Jersey-based Merck & Co., Inc. (MRK) is a global leader in the healthcare ...

U.S. drugmaker Merck & Co on Wednesday announced that its human papillomavirus (HPV) vaccine for men has been approved by ...

Truist downgraded Merck (MRK) to Hold from Buy with a price target of $110, down from $130, as part of a broader research note previewing FY25 ...

The decision to reposition on Merck is attributed to several commercial overhangs, particularly the performance of its Gardasil franchise in China. Despite these challenges, InvestingPro data ...

Merck just rewarded its shareholders again with a dividend hike. This Dow stock has come with a quarterly dividend for almost ...